Stevens-Boris Lakoussan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Stevens-Boris Lakoussan has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Anaïs Karch
Agence régionale de Démoustication, Rosny-sous-Bois, France
1 shared publicationAnaïs Soares
LABORATOIRE EUROFINS BIOMNIS, LYON, France
1 shared publicationAnne Ebel
Laboratoire Eurofins Biomnis, Ivry sur Seine, France
1 shared publication- Anne Fouillet
Santé publique France, Saint-Maurice, France
1 shared publication - Arnaud Tarantola
Santé Publique France (French National Public Health Agency), Cellule Régionale Île-de-France , 13 rue du Landy, 93200 Saint-Denis
1 shared publication Benoit Visseaux
Laboratoire Cerba, Frepillon, France
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 20 June 2024
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 29 (25) , 2400339
An unusual outbreak of parvovirus B19 infections, France, 2023 to 2024
From April 2023 to May 2024, an unusual epidemic of parvovirus B19 (B19V) infections occurred in France. The number of B19V IgM-positive serologies was four times higher than in the previous epidemic in 2019. Clinical data from emergency networks corroborated this observation. Morbidity and mortality consequences were observed in children through all data sources. In adults, the increase was only observed in laboratory-confirmed data. Physicians and decisionmakers should be informed in order to better prevent, diagnose and manage at-risk patients.
- 20 June 2024
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 29 (25) , 2400339
Top Cited PapersOpen AccessAn unusual outbreak of parvovirus B19 infections, France, 2023 to 2024
From April 2023 to May 2024, an unusual epidemic of parvovirus B19 (B19V) infections occurred in France. The number of B19V IgM-positive serologies was four times higher than in the previous epidemic in 2019. Clinical data from emergency networks corroborated this observation. Morbidity and mortality consequences were observed in children through all data sources. In adults, the increase was only observed in laboratory-confirmed data. Physicians and decisionmakers should be informed in order to better prevent, diagnose and manage at-risk patients.
- Open Access
- 7 December 2023
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 28 (49) , 2300641
A cluster of autochthonous dengue transmission in the Paris region – detection, epidemiology and control measures, France, October 2023
A cluster of three confirmed autochthonous dengue cases was detected in October 2023 in the Val-de-Marne department neighbouring Paris, France. This marks the northernmost transmission of dengue in Europe reported to date. The epidemiological and microbiological investigations and the vector control measures are described. This event confirms the need for early case detection and response to contain dengue in Europe, especially given the 2024 Summer Olympic and Paralympic Games, when millions of visitors will visit the Greater Paris area.
- 7 December 2023
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 28 (49) , 2300641
Open AccessA cluster of autochthonous dengue transmission in the Paris region – detection, epidemiology and control measures, France, October 2023
A cluster of three confirmed autochthonous dengue cases was detected in October 2023 in the Val-de-Marne department neighbouring Paris, France. This marks the northernmost transmission of dengue in Europe reported to date. The epidemiological and microbiological investigations and the vector control measures are described. This event confirms the need for early case detection and response to contain dengue in Europe, especially given the 2024 Summer Olympic and Paralympic Games, when millions of visitors will visit the Greater Paris area.